Multiple sclerosis laboratory findings

Jump to navigation Jump to search

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis laboratory findings

CDC on Multiple sclerosis laboratory findings

Multiple sclerosis laboratory findings in the news

Blogs on Multiple sclerosis laboratory findings

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Laboratory Findings

CSF analysis:

CSF analysis mostly used to rule out other differential diagnosis of MS since it’s not needed in MS patients who have typical clinical presentation and MRI findings. The first thing we see in CSF analysis is the appearance and pressure of CSF which is usually normal in MS patients. One of the most important findings in CSF analysis of MS patients is the presence of oligoclonal IgG bands and can be seen in more than 95% of these patients. Oligoclonal bands are an indicator of disease progression.

References

Template:WH Template:WS